Correlation between lymphocyte responsiveness to mitogens and results of chemo-immunotherapy in patients with advanced cancer.

Tetsuya Toge(Hiroshima University), Takao Hattori(Hiroshima University), Hiroshi Ikeda, Minoru Niimoto(Hiroshima University), Yoshitaka Yamada(Hiroshima University)
PubMed
October 1, 1979
Cited by 2

Related Papers

Clinical Aspects of Primary Thyroid Lymphoma: Diagnosis and Treatment Based on Our Experience of 119 Cases
|Thyroid|1993|318
Current status of the molecular mechanisms of anticancer drug-induced apoptosis
|Cancer Chemotherapy and Pharmacology|2002|255
The role of Fas ligand and transforming growth factor β in tumor progression
|Cancer|2004|135
Targeted therapy against Bcl-2-related proteins in breast cancer cells
|Breast Cancer Research|2005|114
Protracted 5-fluorouracil infusion with concurrent radiotherapy as a treatment for locally advanced pancreatic carcinoma
|Cancer|1997|111